AddLife reports positive development with stronger margins and growth
Net sales up 6%, EBITA up 11% in Q2, with two completed acquisitions.
See the latest news and media coverage for AddLife. We track all announcements, press releases, and industry mentions in real time, all in one place.
European life science partner
add.lifeLast updated
In short: AddLife demonstrated strong financial performance with a 6% sales increase in Q2 2026, driven by organic growth and strategic acquisitions.
Net sales up 6%, EBITA up 11% in Q2, with two completed acquisitions.
Over the past year, all CEOs, MDs and VPs completed four modules focused on CEO excellence, strategy, organic growth, and board excellence.
BonsaiLab specializes in niche Medtech and Labtech areas, partnering with Josep Carreras Leukaemia Research Institute to advance genomics against leukaemia.
Resolutions passed include adoption of financial statements, SEK 1.50 dividend per share, board re-elections, new director Fredrik Rågmark, LTIP 2026, and share repurchase authorizations.
AddLife AB ( ($SE:ALIF.B) ) just unveiled an update. AddLife AB reported a solid second quarter, with net sales rising 6% to SEK 2.7 billion...
As of 8:04:10 AM GMT+2. Market Open.
Resolutions, including the following, were passed by the Annual General Meeting ("AGM") and the ensuing statutory Board of Directors Meeting of AddLife AB (the "Company...
This article first appeared on GuruFocus. Release Date: April 28, 2026 For the complete transcript of the earnings call, please refer to the full earnings...
Track AddLife and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to AddLife and other trending companies.